Proteomic characterization of the cellular response to chemopreventive triterpenoid astragaloside IV in human hepatocellular carcinoma cell line HepG2

International Journal of Oncology

Volumn 36, Issue 3, 2010, Pages 725-735

  Qi, Hongyi ^a,b   Wei, Lai ^a,b   Han, Yifan ^c   Zhang, Qinglin ^d   Lau, Allan Sik Yin ^a   Rong, Jianhui ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^d BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Astragaloside IV; Chemoprevention; Gene regulation; Oncogene Vav3; Tumorigenesis

Indexed keywords

ANTIBODY; ASTRAGALOSIDE IV; CELL PROTEIN; PRIMER DNA; UNCLASSIFIED DRUG; VAV 3 PROTEIN; VAV PROTEIN; ASTRAGALOSIDE A; PEPTIDE; PLANT MEDICINAL PRODUCT; SAPONIN; TRITERPENE;

ANCHORAGE INDEPENDENT GROWTH; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATTENUATION; CANCER CELL CULTURE; CELL SURVIVAL; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MASS SPECTROMETRY; MEDICINAL PLANT; PRIORITY JOURNAL; PROTEOMICS; RADIX ASTRAGALI; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LIVER NEOPLASMS; PROCEDURES; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; DNA PRIMERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MASS SPECTROMETRY; PEPTIDES; PLANT PREPARATIONS; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAPONINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRITERPENES;

EID: 77149121747     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000548     Document Type: Article

References (70)

1. Mills JJ, Jirtle RL and Boyer IJ: Mechanism of liver tumor promotion. In: Liver Regeneration and Carcinogenesis. Jirtle RL (ed.) Academic Press, San Diego, pp199-226, 1995.
2. Hueber AO and Evan GI: Traps to catch unwary oncogenes. Trends Genet 14: 364-367, 1998.
3. Lynch DH: Oncogenes and cancer. Am J Reprod Immunol Microbiol 15: 24-28, 1987.
4. Breuhahn K, Longerich T and Schirmacher P: Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 25: 3787-3800, 2006.
5. Vogelstein B and Kinzler KW: Cancer genes and the pathways they control. Nat Med 10: 789-799, 2004.
6. Satoh T, Nakafuku M and Kaziro Y: Function of Ras as a molecular switch in signal transduction. J Biol Chem 267: 24149-24152, 1992.
7. Ramjaun AR and Downward J: Ras and phosphoinositide 3-kinase: partners in development and tumorigenesis. Cell Cycle 6: 2902-2905, 2007.
8. Gulbins E, Schlottmann K, Brenner B, Lang F and Coggeshall KM: Molecular analysis of Ras activation by tyrosine phosphorylated Vav. Biochem Biophys Res Commun 217: 876-885, 1995.
9. Friedman E: The role of ras GTPase activating protein in human tumorigenesis. Pathobiology 63: 348-350, 1995.
10. Malaney S and Daly RJ: The ras signaling pathway in mammary tumorigenesis and metastasis. J Mammary Gland Biol Neoplasia 6: 101-113, 2001.
11. Waldmann V and Rabes HM: What's new in ras genes? Physiological role of ras genes in signal transduction and significance of ras gene activation in tumorigenesis. Pathol Res Pract 192: 883-891, 1996.
12. Feig LA: The many roads that lead to Ras. Science 260: 767-768, 1993.
13. Katzav S, Packham G, Sutherland M, Aroca P, Santos E and Cleveland JL: Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function. Oncogene 11: 1079-1088, 1995.
14. Sachdev P, Zeng L and Wang LH: Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes. J Biol Chem 277: 17638-17648, 2002.
15. Dong Z, Liu Y, Lu S, et al: Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer. Mol Endocrinol 20: 2315-2325, 2006.
16. Liu Y, Mo JQ, Hu Q, et al: Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer. Cancer Res 68: 6396-6406, 2008.
17. Lee K, Liu Y, Mo JQ, Zhang J, Dong Z and Lu S: Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer. BMC Cancer 8: 158, 2008.
18. Liu BP and Burridge K: Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins. Mol Cell Biol 20: 7160-7169, 2000.
19. Lyons LS and Burnstein KL: Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity. Mol Endocrinol 20: 1061-1072, 2006.
20. Abe K, Rossman KL, Liu B, et al: Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem 275: 10141-10149, 2000.
21. Movilla N, Dosil M, Zheng Y and Bustelo XR: How Vav proteins discriminate the GTPases Rac1 and RhoA from Cdc42. Oncogene 20: 8057-8065, 2001.
22. Hornstein I, Alcover A and Katzav S: Vav proteins, masters of the world of cytoskeleton organization. Cell Signal 16: 1-11, 2004.
23. Katzav S, Martin-Zanca D and Barbacid M: vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J 8: 2283-2290, 1989.
24. Khosravi-Far R, Chrzanowska-Wodnicka M, Solski PA, Eva A, Burridge K and Der CJ: Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol Cell Biol 14: 6848-6857, 1994.
25. Inabe K, Ishiai M, Scharenberg AM, Freshney N, Downward J and Kurosaki T: Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation. J Exp Med 195: 189-200, 2002.
26. Hu P, Margolis B and Schlessinger J: Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling. Bioessays 15: 179-183, 1993.
27. Zeng L, Sachdev P, Yan L, et al: Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation. Mol Cell Biol 20: 9212-9224, 2000.
28. Whitehead IP, Campbell S, Rossman KL and Der CJ: Dbl family proteins. Biochim Biophys Acta 1332: F1-F23, 1997.
29. Schmidt A and Hall A: Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 16: 1587-1609, 2002.
30. Etienne-Manneville S and Hall A: Rho GTPases in cell biology. Nature 420: 6629-635 2002.
31. Wang GL, Chen CB, Gao JM, Ni H, Wang TS and Chen L: [Investigation on the molecular mechanisms of anti-hepatocarcinoma herbs of traditional Chinese medicine by cell cycle microarray]. Zhongguo Zhong Yao Za Zhi 30: 50-54, 2005.
32. Krasteva IN, Toshkova RA and Nikolov SD: Protective effect of Astragalus corniculatus saponins against myeloid graffi tumour in hamsters. Phytother Res 18: 255-257, 2004.
33. Tin MM, Cho CH, Chan K, James AE and Ko JK: Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft. Carcinogenesis 28: 1347-1355, 2007.
34. Zhao KW and Kong HY: [Effect of Astragalan on secretion of tumor necrosis factors in human peripheral blood mononuclear cells]. Zhongguo Zhong Xi Yi Jie He Za Zhi 13: 263-265, 1993.
35. Wang DC: [Influence of Astragalus membranaceus (AM) polysaccharide FB on immunologic function of human periphery blood lymphocyte]. Zhonghua Zhong Liu Za Zhi 11: 180-183, 1989.
36. Kim HS, Lee EH, Ko SR, Choi KJ, Park JH and Im DS: Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res 27: 429-435, 2004.
37. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
38. Rong J, Tilton R, Shen J, et al: Genome-wide biological response fingerprinting (BioReF) of the Chinese botanical formulation ISF-1 enables the selection of multiple marker genes as a potential metric for quality control. J Ethnopharmacol 113: 35-44, 2007.
39. Wang LH: Molecular signaling regulating anchorage-independent growth of cancer cells. Mt Sinai J Med 71: 361-367, 2004.
40. Okada M, Jang SW and Ye K: Ebp1 association with nucleophosmin/ B23 is essential for regulating cell proliferation and suppressing apoptosis. J Biol Chem 282: 36744-36754, 2007.
41. Trenkle T, McClelland M, Adlkofer K and Welsh J: Major transcript variants of VAV3, a new member of the VAV family of guanine nucleotide exchange factors. Gene 245: 139-149, 2000.
42. Movilla N and Bustelo XR: Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol Cell Biol 19: 7870-7885, 1999.
43. Lacroix M and Leclercq G: Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 83: 249-289, 2004.
44. Sanchez AM, Sanchez MG, Malagarie-Cazenave S, Olea N and Diaz-Laviada I: Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin. Apoptosis 11: 89-99, 2006.
45. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780, 2003.
46. Schlesinger MJ: Heat shock proteins. J Biol Chem 265: 12111-12114, 1990.
47. Arya R, Mallik M and Lakhotia SC: Heat shock genes - integrating cell survival and death. J Biosci 32: 595-610, 2007.
48. Pittet JF, Lee H, Pespeni M, O'Mahony A, Roux J and Welch WJ: Stress-induced inhibition of the NF-kappaB signaling pathway results from the insolubilization of the IkappaB kinase complex following its dissociation from heat shock protein 90. J Immunol 174: 384-394, 2005.
49. Stanley WM Jr, Salas M, Wahba AJ and Ochoa S: Translation of the genetic message: factors involved in the initiation of protein synthesis. Proc Natl Acad Sci USA 56: 290-295, 1966.
50. Asano K, Kinzy TG, Merrick WC and Hershey JW: Conservation and diversity of eukaryotic translation initiation factor eIF3. J Biol Chem 272: 1101-1109, 1997.
51. Chen RH, Miettinen PJ, Maruoka EM, Choy L and Derynck R: A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor. Nature 377: 548-552, 1995.
52. Galicia-Vazquez G, Lindqvist L, Wang X, Harvey I, Liu J and Pelletier J: High-throughput assays probing protein-RNA interactions of eukaryotic translation initiation factors. Anal Biochem 384: 180-188, 2009.
53. Runnels LW, Yue L and Clapham DE: TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291: 1043-1047, 2001.
54. Nadler MJ, Hermosura MC, Inabe K, et al: LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature 411: 590-595, 2001.
55. Runnels LW, Yue L and Clapham DE: The TRPM7 channel is inactivated by PIP(2) hydrolysis. Nat Cell Biol 4: 329-336, 2002.
56. Jiang J, Li MH, Inoue K, Chu XP, Seeds J and Xiong ZG: Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation. Cancer Res 67: 10929-10938, 2007.
57. Wykes RC, Lee M, Duffy SM, Yang W, Seward EP and Bradding P: Functional transient receptor potential melastatin 7 channels are critical for human mast cell survival. J Immunol 179: 4045-4052, 2007.
58. Zhang K, Howes KA, He W, et al: Structure, alternative splicing, and expression of the human RGS9 gene. Gene 240: 23-34, 1999.
59. Nishiguchi KM, Sandberg MA, Kooijman AC, et al: Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation. Nature 427: 75-78, 2004.
60. Ferrari AC, Seuanez HN, Hanash SM and Atweh GF: A gene that encodes for a leukemia-associated phosphoprotein (p18) maps to chromosome bands 1p35-36.1. Genes Chromosomes Cancer 2: 125-129, 1990.
61. Melhem RF, Zhu XX, Hailat N, Strahler JR and Hanash SM: Characterization of the gene for a proliferation-related phosphoprotein (oncoprotein 18) expressed in high amounts in acute leukemia. J Biol Chem 266: 17747-17753, 1991.
62. Sobel A: Stathmin: a relay phosphoprotein for multiple signal transduction? Trends Biochem Sci 16: 301-305, 1991.
63. Olsen JV, Blagoev B, Gnad F, et al: Global, in vivo, and sitespecific phosphorylation dynamics in signaling networks. Cell 127: 635-648, 2006.
64. Thiesen HJ: Multiple genes encoding zinc finger domains are expressed in human T cells. New Biol 2: 363-374, 1990.
65. Shannon M and Stubbs L: Analysis of homologous XRCC1-linked zinc-finger gene families in human and mouse: evidence for orthologous genes. Genomics 49: 112-121, 1998.
66. Tsujimoto M, Tsuruoka N, Ishida N, et al: Purification, cDNA cloning, and characterization of a new serpin with megakaryocyte maturation activity. J Biol Chem 272: 15373-15380, 1997.
67. Miyata T, Nangaku M, Suzuki D, et al: A mesangiumpredominant gene, megsin, is a new serpin upregulated in IgA nephropathy. J Clin Invest 102: 828-836, 1998.
68. Inagi R, Nangaku M, Usuda N, et al: Novel serpinopathy in rat kidney and pancreas induced by overexpression of megsin. J Am Soc Nephrol 16: 1339-1349, 2005.
69. Abe K, Whitehead IP, O'Bryan JP and Der CJ: Involvement of NH(2)-terminal sequences in the negative regulation of Vav signaling and transforming activity. J Biol Chem 274: 30410-30418, 1999.
70. Groysman M, Nagano M, Shaanan B and Katzav S: Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation. Oncogene 17: 1597-1606, 1998.